Safety and immunogenicity of Ad26.COV2.S in adolescents: phase 2 randomized clinical trial (2025)
- Authors:
- Autor USP: MUSSI, MARISA MARCIA - FMRP
- Unidade: FMRP
- DOI: 10.1080/21645515.2025.2450120
- Subjects: VACINAS; ADOLESCENTES; IMUNOGENICIDADE DA VACINA
- Keywords: Ad26.COV2.S; COVID-19 vaccine; Adolescent; Dose-range study; Immunogenicity; Safety; Shelf life; Virus vector vaccine
- Language: Inglês
- Imprenta:
- Source:
- Título: Human Vaccines & Immunotherapeutics
- ISSN: 2164-5515
- Volume/Número/Paginação/Ano: v. 21, n. 1, art. 2450120, p. 1-12, 2025
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
TICA, Jelena et al. Safety and immunogenicity of Ad26.COV2.S in adolescents: phase 2 randomized clinical trial. Human Vaccines & Immunotherapeutics, v. 21, n. 1, p. 1-12, 2025Tradução . . Disponível em: https://doi.org/10.1080/21645515.2025.2450120. Acesso em: 25 fev. 2026. -
APA
Tica, J., Rezelj, V. V., Baron, B., Zaidman, J., Fairlie, L., Scheper, G., et al. (2025). Safety and immunogenicity of Ad26.COV2.S in adolescents: phase 2 randomized clinical trial. Human Vaccines & Immunotherapeutics, 21( 1), 1-12. doi:10.1080/21645515.2025.2450120 -
NLM
Tica J, Rezelj VV, Baron B, Zaidman J, Fairlie L, Scheper G, Struyf F, Douoguih M, Le Gars M, Mussi MM. Safety and immunogenicity of Ad26.COV2.S in adolescents: phase 2 randomized clinical trial [Internet]. Human Vaccines & Immunotherapeutics. 2025 ; 21( 1): 1-12.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1080/21645515.2025.2450120 -
Vancouver
Tica J, Rezelj VV, Baron B, Zaidman J, Fairlie L, Scheper G, Struyf F, Douoguih M, Le Gars M, Mussi MM. Safety and immunogenicity of Ad26.COV2.S in adolescents: phase 2 randomized clinical trial [Internet]. Human Vaccines & Immunotherapeutics. 2025 ; 21( 1): 1-12.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1080/21645515.2025.2450120 - Quality assurance program for peripheral blood mononuclear cell cryopreservation
- Neurologic outcomes in HIV-exposed/uninfected infants exposed to antiretroviral drugs during pregnancy in Latin America and the Caribbean
- Undervaccination of perinatally HIV-infected and HIV-exposed uninfected children in Latin America and the Caribbean
- Clinical profile of HIV-infected adolescents in Latin America: preliminary report of NICHD international site development initiative pediatric study
- Recem-nascido de baixo peso
- NICDH International Site Developmental Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries
- Laboratory-based surveillance of streptococcus pneumoniae invasive disease (IPD) in children: serotype distribution and estimation of vaccines coverage
- Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants
- Congenital and perinatal cytomegalovirus infection
- Altered natural killerr cell function in HIV-exposed uninfected infants
Informações sobre o DOI: 10.1080/21645515.2025.2450120 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003250198.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
